EXG™ 12-Lead Wearable ECG — Continuous Diagnostic Monitoring, 3-Day Wear, Radiolucent

The flagship EXG™ configuration — 12-Lead diagnostic ECG in a wearable form factor

The EXG™ 12-Lead Wearable ECG is the flagship configuration of the EXG™ platform from C-Booth Innovations. It delivers continuous 12-Lead diagnostic monitoring in a wearable that goes on in under 60 seconds and stays on for up to three days — tolerating diaphoresis and showering across the episode of care.

Now available through Heart Medical for U.S. hospitals, EMS agencies, and cath labs.

Why the flagship configuration matters

Standard 12-Lead ECG carries a documented electrode misapplication rate of 94.2% (Rouan et al., Am J Cardiol 1989; 64(18):1087–1092), and just 2 cm of misplacement can obscure critical ST-segment changes and hide a heart attack (Bond et al. 2012). The EXG™ 12-Lead addresses these failures at the source: the wearable form factor places electrodes at consistent anatomical positions across ED, ICU, medical/surgical, and cardiology, regardless of who deploys it or where.

Key features — 12-Lead configuration

• Continuous diagnostic 12-Lead monitoring across the entire episode of care
• Expandable to 18-Lead for Right-sided and Posterior visualization — pair with the EXG™ 3-Lead reversible
• 3-day continuous wear — once skin is prepped, can be worn through diaphoresis and showering for extended monitoring
• CPR compatible — tolerates Manual & Mechanical CPR (LUCAS); wearable stays on during resuscitation
• Radiolucent design — supports continuous 12-Lead monitoring throughout imaging procedures without repositioning
• Single-cable design — single connection enables setup in under 60 seconds; one adapter works across every EXG™ configuration
• AHA-compliant electrode placement
• Disposable, per-patient — single-use consumable
• Universal compatibility — one cable fits any standard ECG monitor

Clinical applications

• EMS / prehospital STEMI transport — 12-Lead ECG in under 60 seconds, motion artifact reduction, universal compatibility with LP15, X Series, and other portable ECG monitors
• Emergency department triage and continuous diagnostic monitoring
• ICU and critical care — continuous 12-Lead across multi-day admissions
• Cardiology consults and pre-stress-echo assessment
• Cath lab procedures — continuous 12-Lead through diagnostic cath, PCI, TAVR planning, MitraClip delivery (radiolucent, CPR compatible)
• Peri-procedural monitoring in recovery bays

Certifications and compliance

Certified for professional medical use: FDA-Registered, AHA-Compliant & ISO-13485 Certified.

About C-Booth Innovations

EXG™ is manufactured by C-Booth Innovations, a Carlsbad, California medical-technology company founded in 2017 by two emergency room physicians.

Explore other configurations

The 12-Lead is one of four EXG™ configurations. See the full platform overview at the EXG™ Wearable ECG Platform collection page, or explore the other configurations directly:

• EXG™ 5-Lead — continuous rhythm monitoring
• EXG™ 4-Lead (4-Electrode) — EMS rate & rhythm monitoring
• EXG™ 3-Lead (Reversible) — Right-sided + Posterior visualization

Purchase and configuration workflow

1. Request a scoped quote. Share the audience (EMS, hospital, or cath lab), volume estimate, and existing ECG monitor infrastructure.
2. Configuration walkthrough. Confirm 12-Lead is the right primary configuration and whether you also need 3-Lead reversible or 5-Lead alongside.
3. Deployment planning. Coordinate with your biomed / clinical engineering team on integration and applications training.
4. Standing-order supply. EXG™ 12-Lead is disposable per-patient — predictable-volume programs benefit from standing-order setup.

Request a Quote → or call +1 (833) 409-4600. Our team responds within one business day.